Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

October 01, 2016; Volume 359,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aaltonen, Niina

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  2. Abagyan, Ruben

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  3. Abbott, Megan

    1. You have access
      Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252
  4. Adili, Reheman

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      You have access
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781
  5. Ai, Jing

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      You have access
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799
  6. Al-Khrasani, Mahmoud

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  7. Alonso-Galicia, Magdalena

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  8. Alston, Laurie

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

B

  1. Balac, Natasha

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  2. Balogh, Mihály

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  3. Banfor, Patricia

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  4. Benetti, Elisa

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069
  5. Bousquet, Peter

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  6. Brodeur, Scott R.

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  7. Brown, Nicholas F.

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  8. Bui, Hai H.

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  9. Bush, Kevin T.

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

C

  1. Can, Adem

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  2. Cerny, Matthew A.

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  3. Chang, Thomas K. H.

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096
  4. Cheer, Joseph F.

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  5. Chen, Bi

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      You have access
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799
  6. Chen, Gang

    1. You have access
      Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044
  7. Chen, Y. Eugene

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  8. Chen, Yuchen

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  9. Chiazza, Fausto

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069
  10. Chiu, Weihsueh A.

    1. You have access
      Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629
  11. Cichocki, Joseph A.

    1. You have access
      Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629
  12. Cogan, Derek

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  13. Collino, Massimo

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069
  14. Collins, Gregory T.

    1. You have access
      Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252
  15. Cornic, Laura

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  16. Corona, Aaron

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  17. Csekő, Kata

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  18. Cutrin, Juan Carlos

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

D

  1. Das, Aditi

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      You have access
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781
  2. DeWire, Scott M.

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  3. Dluzen, Douglas F.

    1. You have access
      Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044
  4. Dossou, Katinia S. S.

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  5. Duignan, David B.

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

E

  1. Eberhardt, Esther

    1. You have access
      Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452
  2. Eberhardt, Mirjam

    1. You have access
      Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452
  3. Eitzman, Daniel T.

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  4. Erickson, Sarah L.

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

F

  1. Fantozzi, Roberto

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069
  2. Felix, John P.

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  3. Ferdinandy, Péter

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  4. France, Charles P.

    1. You have access
      Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252
  5. Freissmuth, Michael

    1. You have access
      Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884
  6. Frost, Douglas O.

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  7. Funakoshi, Kodai

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  8. Fürst, Susanna

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

G

  1. Galindo, Kayla

    1. You have access
      Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252
  2. Garcia, Maria L.

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  3. Garg, Aditya

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096
  4. Gill, Charles

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  5. Gintant, Gary

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  6. Giricz, Zoltán

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  7. Goldenberg, Anne

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  8. Gould, Todd D.

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  9. Gueneva-Boucheva, Kristina

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  10. Guha, Neela

    1. You have access
      Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629
  11. Guo, Xin

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  12. Guyton, Kathryn Z.

    1. You have access
      Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629
  13. Gynther, Mikko

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

H

  1. Hampton, Caryn

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  2. Harris, Christopher M.

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  3. Hart, Michelle

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  4. Helyes, Zsuzsanna

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  5. Hirota, Simon A.

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096
  6. Holinstat, Michael

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      You have access
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781
  7. Hollenberg, Paul F.

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  8. Hopkins, Mandi M.

    1. You have access
      Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells
      Mandi M. Hopkins, Ze Liu and Kathryn E. Meier
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 124-133; DOI: https://doi.org/10.1124/jpet.116.233379
  9. Hosztafi, Sándor

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  10. Huang, Xi-Ping

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

I

  1. Inami, Keita

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  2. Ishmael, Faoud T.

    1. You have access
      Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044

J

  1. Jakupovic, Hermina

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  2. Jiang, Handong

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      You have access
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799
  3. Jones, Spencer B.

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

K

  1. Kaczorowski, Gregory J.

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  2. Kang, Hye Jin

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  3. Kanno, Shuichi

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  4. Kedzierska, Ewa

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  5. Kenny, Cynthia Hess

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  6. Khalil, Ashraf M.

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  7. Kim, Youngjae

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  8. Király, Kornél

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  9. Kohler, Martin

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  10. Korzekwa, Kenneth

    1. You have access
      Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport
      Priyanka Kulkarni, Kenneth Korzekwa and Swati Nagar
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 26-36; DOI: https://doi.org/10.1124/jpet.116.235689
  11. Kulkarni, Priyanka

    1. You have access
      Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport
      Priyanka Kulkarni, Kenneth Korzekwa and Swati Nagar
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 26-36; DOI: https://doi.org/10.1124/jpet.116.235689
  12. Kulmacz, Richard

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      You have access
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781
  13. Kumagai, Takeshi

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

L

  1. Lackó, Erzsébet

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  2. Laitinen, Jarmo T.

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  3. Lash, Lawrence H.

    1. You have access
      Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629
  4. Lau, Aik Jiang

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096
  5. Lauver, D. Adam

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  6. Lazarus, Philip

    1. You have access
      Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044
  7. Leffler, Andreas

    1. You have access
      Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452
  8. Lehtonen, Marko

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  9. Li, Chenhong

    1. You have access
      Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817
  10. Li, Yixuan

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      You have access
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799
  11. Li, Zhen

    1. You have access
      Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817
  12. Liu, Henry C.

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  13. Liu, Jessica

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  14. Liu, Ze

    1. You have access
      Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells
      Mandi M. Hopkins, Ze Liu and Kathryn E. Meier
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 124-133; DOI: https://doi.org/10.1124/jpet.116.233379
  15. Lun, Christina

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  16. Luo, Fang

    1. You have access
      Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817

M

  1. Mani, Sridhar

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096
  2. Mastrocola, Raffaella

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069
  3. Matsui, Satomi

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  4. Mayoux, Eric

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069
  5. McCann, Denis J.

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  6. Meier, Kathryn E.

    1. You have access
      Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells
      Mandi M. Hopkins, Ze Liu and Kathryn E. Meier
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 124-133; DOI: https://doi.org/10.1124/jpet.116.233379
  7. Metzger, Joseph M.

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  8. Mittelstadt, Scott

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  9. Moaddel, Ruin

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  10. Moss, Neil

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  11. Mousa, Shaaban A.

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  12. Mukherjee, Subhajit

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

N

  1. Nagar, Swati

    1. You have access
      Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport
      Priyanka Kulkarni, Kenneth Korzekwa and Swati Nagar
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 26-36; DOI: https://doi.org/10.1124/jpet.116.235689
  2. Nagata, Kiyoshi

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  3. Nanoff, Christian

    1. You have access
      Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884
  4. Nasrollahi-Shirazi, Shahrooz

    1. You have access
      Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884
  5. Navia-Paldanius, Dina

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  6. Nevalainen, Tapio

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  7. Nicoletti, Amy M.

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  8. Nigam, Sanjay K.

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  9. Nigro, Debora

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069
  10. Norman, Bryan H.

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  11. Numata, Yoshihiro

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

O

  1. Ormes, James

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  2. Orzelska-Górka, Jolanta

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  3. Osawa, Yoichi

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  4. Owens, Karen

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

P

  1. Pai, Lee-Yuh

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  2. Pan, Qi

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  3. Parkkari, Teija

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  4. Parmentier, Jean-Hugues

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  5. Pasternak, Alexander

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  6. Pfeifer, Lance A.

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  7. Presky, David H.

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  8. Price, Olga

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  9. Priest, Birgit T.

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

R

  1. Ralph, Kerry L. M.

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  2. Rasa, Cordelia

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  3. Reinhart, Glenn A.

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  4. Riba, Pál

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  5. Rice, Kenner C.

    1. You have access
      Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252
  6. Richman, Jeremy R.

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  7. Ritchie, Julie

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  8. Rocha, Guilherme

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  9. Rodriguez, Paul

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660
  10. Roy, Jahnabi

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      You have access
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781
  11. Roy, Sophie

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  12. Rush, Elise L.

    1. You have access
      Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252
  13. Rusyn, Ivan

    1. You have access
      Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629

S

  1. Saha, Joy K.

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  2. Sasaki, Takamitsu

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  3. Savinainen, Juha R.

    1. You have access
      In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114
  4. Schäfer, Michael

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  5. Schillers, Florian

    1. You have access
      Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452
  6. Segreti, Jason

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      You have access
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002
  7. Shah, Kashmira

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  8. Sucic, Sonja

    1. You have access
      Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884
  9. Sullivan, Kathleen A.

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  10. Sun, Duxin

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  11. Sun, Guangqiang

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      You have access
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799
  12. Sutliff, Aimee K.

    1. You have access
      Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044
  13. Swearingen, Craig A.

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

T

  1. Tan, Bailin

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  2. Tang, Haifeng

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  3. Thirunavukkarasu, Kannan

    1. You have access
      Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013
  4. Thomas-Fowlkes, Brande

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  5. Tong, Vince

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
  6. Toriyabe, Takayoshi

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

V

  1. Váradi, András

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  2. Venkataramani, Sathyadevi

    1. You have access
      Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
  3. Vitarelli, Giovanna

    1. You have access
      Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

W

  1. Wainer, Irving W.

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  2. Wang, Hui

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  3. Wang, Zaijie Jim

    1. You have access
      Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817
  4. Watson, Christy J. W.

    1. You have access
      Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044
  5. Weldon, Steven M.

    1. You have access
      Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463
  6. Wu, Wei

    1. You have access
      Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

X

  1. Xiao, Jianying

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

Y

  1. Yamazoe, Yasushi

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  2. Yang, Qiong

    1. You have access
      Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884
  3. Yin, Pingping

    1. You have access
      Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817
  4. Yoshida, Midori

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  5. Yoshinari, Kouichi

    1. You have access
      Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
  6. You, Wenjie

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      You have access
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

Z

  1. Zádori, Zoltán Sándor

    1. You have access
      New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551
  2. Zanos, Panos

    1. You have access
      Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838
  3. Zhang, Haoming

    1. You have access
      Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034
  4. Zhao, Angela

    1. You have access
      Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096
  5. Zhou, Ji

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      You have access
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799
  6. Zhou, Xiaoyan

    1. You have access
      The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 359 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 359, Issue 1
1 Oct 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics